EQTEC PLC

Share Issue/Capital Change • May 31, 2018

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7582P

EQTEC PLC

31 May 2018

31 May 2018

EQTEC plc

("EQTEC" or the "Company")

Issue of Shares

EQTEC plc (AIM: EQT), the technology solution company for waste gasification to energy projects, has agreed with EBIOSS Energy SE ("EBIOSS"), its major shareholder, to convert a receivable owned by EBIOSS in the amount of £87,000 into 29,000,000 ordinary shares in the Company at a conversion price of 0.3p which is the same conversion price as the 33,333,333 ordinary shares being issued pursuant to the loan note conversion announced on 25 May 2018.

Upon issue, EBIOSS will hold 742,381,371 ordinary shares, comprising 50.06% of the enlarged issued share capital of the Company.

Application will be made for the admission to AIM of these new ordinary shares together with the 33,333,333 ordinary shares being issued pursuant to the loan note conversion and trading is expected to start on 5 June 2018.

Enquiries

EQTEC plc	+353 (0)21 2409 056
Luis Sanchez - Chief Executive Officer Gerry Madden - Finance Director
Northland Capital Partners Limited - Nomad and Joint Broker	+44 (0)20 3861 6625
Tom Price / Dugald J. Carlean
VSA Capital Limited - Joint Broker	+44 (0)20 3005 5000
Andrew Monk / Andrew Raca
Luther Pendragon - Financial PR	+44 (0)20 7618 9100
Harry Chathli / Alexis Gore / Ana Ribeiro

This announcement contains inside information as defined in Article 7 of the EU Market Abuse Regulation No 596/2014 and has been announced in accordance with the Company's obligations under Article 17 of that Regulation.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

IOELLFITETIIVIT